Programmable RNA editing enables reversible recoding of RNA information for research and disease treatment. Previously, we developed a programmable adenosine-to-inosine (A-to-I) RNA editing approach by fusing catalytically inactivate RNA-targeting CRISPR-Cas13 (dCas13) with the adenine deaminase domain of ADAR2. Here, we report a cytidine-to-uridine (C-to-U) RNA editor, referred to as RNA Editing for Specific C-to-U Exchange (RESCUE), by directly evolving ADAR2 into a cytidine deaminase. RESCUE doubles the number of mutations targetable by RNA editing and enables modulation of phosphosignaling-relevant residues. We apply RESCUE to drive b-catenin activation and cellular growth. Furthermore, RESCUE retains A-to-I editing activity, enabling multiplexed C-to-U and A-to-I editing through the use of tailored guide RNAs.
W e previously developed a RNA base editing technology called REPAIR [RNA Editing for Programmable A-to-I (G) Replacement], which uses the RNAtargeting CRISPR effector Cas13 (1) (2) (3) (4) (5) (6) to direct the catalytic domain of ADAR2 to specific RNA transcripts to achieve adenineto-inosine conversion with single-base precision (7) . However, REPAIR, along with a number of other RNA editing technologies (8) (9) (10) (11) (12) (13) (14) (15) , only allows for A-to-I conversions. Technologies for precise RNA editing of cytidine-to-uridine conversions would greatly expand the range of addressable disease mutations and protein modifications (fig. S1A).
Although natural enzymes capable of catalyzing C-to-U conversion have been harnessed for DNA base editing (16, 17) , they only operate on single-stranded substrates (18) , exhibit offtargets (19) (20) (21) , and deaminate multiple bases within a window. Therefore, we took a synthetic approach to evolve the adenine deaminase domain of ADAR2 (ADAR2dd), which naturally acts on double-stranded RNA (dsRNA) substrates and preferentially deaminates a target adenine mispaired with a cytidine, into a cytidine deaminase. We fused this evolved cytidine deaminase to catalytically inactive Cas13 (dCas13) to develop programmable RNA Editing for Specific C-to-U Exchange (RESCUE) in mammalian cells ( fig. S1B ), which we used to activate b-catenin and modulate cell growth. Last, we improved the specificity of RESCUE more than 10-fold via rational mutagenesis, generating a highly specific and precise C-to-U RNA editing tool.
Comparison of the Escherichia coli cytidine deaminase and the human ADAR2dd showed pronounced structural homology between their catalytic cores (22) , suggesting the possibility of evolving ADAR2dd into a cytidine deaminase (fig. S1B). We selected residues of ADAR2dd contacting the RNA substrate (23) for three rounds of rational mutagenesis on an ADAR2dd fused to the catalytically inactive Cas13b ortholog from Riemerella anatipestifer (dRanCas13b), yielding RESCUE round 3 (RESCUEr3) with 15% editing activity (Fig. 1, A and B, and figs. S2 and S3). We then began directed evolution across ADAR2dd to identify additional candidate mutations that increase the activity of RESCUE in yeast (see supplementary materials and methods and table S1). Sixteen rounds of evolution, culminating with the final construct RESCUEr16 (hereafter referred to as simply RESCUE), resulted in increased cytidine deamination activity across all target combinations of neighboring 5′ and 3′ bases (Fig. 1C and figs. S4 to S7). We additionally characterized guide features necessary for robust activity, finding that RESCUE is optimally active with C or U base-flips across the target base using a 30-nucleotide guide (Fig. 1C and figs. S8 to S9). Moreover, as dRanCas13b and the catalytically inactive Cas13b ortholog from Prevotella sp. P5-125 (dPspCas13b) were equivalent, the final RESCUE construct used dRanCas13b ( fig. S10 ).
The 16 mutations in RESCUE are distributed throughout the structure of ADAR2dd (fig. S11A), indicating both direct interactions of the evolved residues with the RNA target within the catalytic pocket as well as indirect effects ( fig. S11B ). These mutations enable fitting of either adenosine or cytidine, as RESCUE is capable of both adenosine and cytidine deamination ( fig. S12) . We evaluated the role of each mutant by individually adding them to REPAIR or removing them from RESCUE (fig. S13). We found that mutations in the catalytic core [V351→G (V351G), K350I] and contacting the RNA target (S486A, S495N) were integral to RESCUE activity, whereas others had minor effects. Biochemical characterization of RESCUE mutations on purified ADAR2dd showed no activity on double-stranded DNA, single-stranded DNA, or DNA-RNA heteroduplexes, with the evolved mutations improving the kinetics of C-to-U editing on dsRNA substrates in vitro ( fig. S14 ). We also found that ADAR2 or alternative RNA editing platforms without Cas13 (8, 9, 11, 13, 24) with introduced RESCUE mutations had markedly reduced editing functionality compared with Cas13b-based RESCUE (Fig. 1D and figs. S15 to S18).
We next evaluated the efficiency of RESCUE on endogenous transcripts in human embryonic kidney (HEK) 293FT cells via bulk sequencing of cell populations. We tested a variety of guide designs across 24 different sites across nine genes, as well as on 24 synthetic disease-relevant mutation targets from ClinVar, and found editing rates up to 42% (Fig. 1E , figs. S19 to S22, and table S2). Across the guides tested (tables S3 to S5), we found multiple guide design rules, most notably related to features of the motif (5′ U or A preferred) and guide mismatch position (see supplementary materials and methods).
We next applied RESCUE to alter activation of the STAT and Wnt/b-catenin pathways via modulation of key phosphorylation residues, which inhibits ubiquitination and degradation (25) (Fig. 2, A and B, and fig. S23 ). We tested a panel of guides targeting the b-catenin transcript (CTNNB1) at known phosphorylation residues and observed editing levels between 5 and 28% (Fig. 2C) , resulting in up to fivefold activation of Wnt/b-catenin signaling (Fig. 2D ) and increased cell growth in HEK293FT (Fig. 2, E and F) and human umbilical vein endothelial cells (HUVECs) (fig. S24 ). Given that therapeutic applications with RESCUE will require shorter constructs for viral delivery, we also evaluated RESCUE activity with C-terminal truncations of dRanCas13b and found either similar or improved deaminase activity ( fig. S25) .
Because RESCUE retains adenosine deaminase activity ( fig. S12) , the native pre-CRISPR RNA (pre-crRNA) processing activity of Cas13b (4) enables multiplexed adenine and cytosine deamination. By delivering RESCUE along with a pre-crRNA targeting an adenine and a cytosine in the CTNNB1 transcript (Fig. 3A) , we found that RESCUE could edit both targeted residues S33F and T41A at rates of~15 and 5%, respectively (Fig. 3B) . However, in these experiments, as well as single-plex assays, we found A-to-I offtargets near the targeted cytosine (figs. S26 and S27). To eliminate these off-targets, we introduced disfavorable guanine mismatches in the guide across from off-target adenosines (Fig.  3C) , significantly reducing off-target editing while minimally disrupting the on-target editing (Fig. 3D) .
Because of off-targets observed near the target site, we profiled off-targets with wholetranscriptome RNA-sequencing, finding that although RESCUE performed~80% C-to-U editing on the Gluc transcript (Fig. 4A) , it created 188 C-to-U off-targets and 1695 A-to-I off-targets, comparable to A-to-I off-targeting with REPAIRv1 (7) (Fig. 4, A and B) . We thus performed rational mutagenesis of ADAR2dd at residues interacting with the RNA target (Fig. 4C) , resulting in RESCUE mutants with improved specificity (Fig. 4, D to G) . The mutant with the highest specificity, S375A on RESCUE (hereafter referred to as RESCUE-S), maintained~76% on-target C-to-U editing (Fig. 4E) and created only 103 Cto-U off-targets and 139 A-to-I off-targets (Fig. 4 , E to G), with reduced missense mutations and differentially regulated transcripts (figs. S28 to S31). We also found that RESCUE-S retained efficiency similar to that of RESCUE at endogenous sites with higher specificity (figs. S32 to S34). Abudayyeh RESCUE is a programmable base editing tool capable of precise cytidine-to-uridine conversion in RNA. Using directed evolution, we demonstrate that adenosine deaminases can be relaxed to accept other bases, resulting in a cytidine deamination mechanism that facilitates dsRNA editing. The larger targetable amino acid codon space of RESCUE enables modulation of more posttranslational modifications, such as phosphorylation, glycosylation, and methylation, as well as expanded targeting of common catalytic residues, disease mutations, and protective alleles, such as ApoE2 (figs. S1 and S35). Overall, RESCUE extends the base editing functionality of the RNA-targeting toolkit, allowing for expanded modeling and potential treatment of genetic diseases.
